Acadian Asset Management Portfolio holdings
AUM
$48.4B
This Quarter Return
+22.68%
1 Year Return
+32.04%
3 Year Return
+133.69%
5 Year Return
+272.69%
10 Year Return
+761.99%
AUM
$23.2B
AUM Growth
+$23.2B
(+33%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
10.6%
Top 10 Holdings %
Top 10 Hldgs %
19.72%
Holding
2,424
New
636
Increased
640
Reduced
743
Closed
211
Top Buys
| 1 |
Apple
AAPL
|
$371M |
| 2 |
Amazon
AMZN
|
$344M |
| 3 |
Baidu
BIDU
|
$291M |
| 4 |
Kroger
KR
|
$163M |
| 5 |
Elevance Health
ELV
|
$159M |
Top Sells
| 1 |
Royal Bank of Canada
RY
|
$206M |
| 2 |
JD.com
JD
|
$124M |
| 3 |
Home Depot
HD
|
$110M |
| 4 |
NXP Semiconductors
NXPI
|
$94.5M |
| 5 |
Sun Life Financial
SLF
|
$88.2M |
Sector Composition
| 1 | Technology | 23.6% |
| 2 | Healthcare | 19.91% |
| 3 | Communication Services | 12.28% |
| 4 | Consumer Discretionary | 12.02% |
| 5 | Consumer Staples | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Intel
INTC
$106B
| $165M | 0.71% |
2,764,007
+384,729
| +16% | +$23M |
|
27
BCE
BCE
$23.3B
| $163M | 0.7% |
3,906,380
-313,860
| -7% | -$13.1M |
|
|
28
Elevance Health
ELV
$71.8B
| $159M | 0.69% |
+605,172
| New | +$159M |
|
29
Cadence Design Systems
CDNS
$95.5B
| $159M | 0.68% |
1,657,653
-425,022
| -20% | -$40.8M |
|
30
Clorox
CLX
$14.5B
| $150M | 0.64% |
682,362
+578,251
| +555% | +$127M |
|
31
United Therapeutics
UTHR
$13.8B
| $146M | 0.63% |
1,206,206
+420,777
| +54% | +$50.9M |
|
32
Amdocs
DOX
$9.41B
| $144M | 0.62% |
2,371,005
+74,825
| +3% | +$4.56M |
|
33
Atlassian
TEAM
$46.6B
| $138M | 0.6% |
768,121
+252,545
| +49% | +$45.5M |
|
34
Kimberly-Clark
KMB
$42.7B
| $138M | 0.59% |
+976,007
| New | +$138M |
|
35
Universal Health Services
UHS
$11.6B
| $138M | 0.59% |
1,481,979
+144,580
| +11% | +$13.4M |
|
36
Walmart
WMT
$780B
| $138M | 0.59% |
1,148,830
-1,837
| -0.2% | -$220K |
|
37
AT&T
T
$208B
| $131M | 0.56% |
4,321,976
-218,610
| -5% | -$6.61M |
|
38
Merck
MRK
$214B
| $128M | 0.55% |
1,657,076
+857,133
| +107% | +$66.3M |
|
39
Reliance Steel & Aluminium
RS
$15.5B
| $127M | 0.55% |
1,340,976
-16,195
| -1% | -$1.54M |
|
40
Bio-Rad Laboratories Class A
BIO
$8.06B
| $120M | 0.52% |
+265,367
| New | +$120M |
|
41
Amgen
AMGN
$155B
| $120M | 0.51% |
+506,956
| New | +$120M |
|
|
AMED
42
DELISTED
Amedisys
AMED
| $118M | 0.51% |
+592,019
| New | +$118M |
|
43
Pfizer
PFE
$142B
| $117M | 0.51% |
3,592,916
+2,163,632
| +151% | +$70.8M |
|
44
Oracle
ORCL
$633B
| $116M | 0.5% |
2,106,028
+1,320,334
| +168% | +$73M |
|
45
Gilead Sciences
GILD
$140B
| $114M | 0.49% |
1,477,469
+649,946
| +79% | +$50M |
|
46
Encompass Health
EHC
$12.3B
| $113M | 0.49% |
1,821,121
-115,822
| -6% | -$7.17M |
|
47
Quest Diagnostics
DGX
$20.3B
| $112M | 0.48% |
984,133
-33,482
| -3% | -$3.82M |
|
48
Medtronic
MDT
$120B
| $110M | 0.47% |
1,202,295
-180,254
| -13% | -$16.5M |
|
49
Berkshire Hathaway Class B
BRK.B
$1.08T
| $110M | 0.47% |
+615,459
| New | +$110M |
|
|
JNPR
50
DELISTED
Juniper Networks
JNPR
| $109M | 0.47% |
4,780,344
+2,220,578
| +87% | +$50.8M |
|